Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast.

Leonardi MC, Spoto R, Miglietta E, Trivellato S, La Rocca E, Luraschi R, Grosso P, De Lorenzi F, Fodor C, Dicuonzo S, Dell'Acqua V, Gerardi MA, Morra A, Francia CM, Rietjens M, Galimberti VE, Veronesi P, Orecchia R, Cattani F, Jereczek-Fossa BA.

J Cancer Res Clin Oncol. 2019 May 29. doi: 10.1007/s00432-019-02938-8. [Epub ahead of print]

PMID:
31144158
2.

New missense variants of NDUFA11 associated with late-onset myopathy.

Peverelli L, Legati A, Lamantea E, Nasca A, Lerario A, Galimberti V, Ghezzi D, Lamperti C.

Muscle Nerve. 2019 May 10. doi: 10.1002/mus.26511. [Epub ahead of print] No abstract available.

PMID:
31074871
3.

De-escalation treatment of axilla in breast cancer.

Corso G, Galimberti V, Veronesi P.

Clin Transl Oncol. 2019 May 9. doi: 10.1007/s12094-019-02129-4. [Epub ahead of print] No abstract available.

PMID:
31073973
4.

Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips.

Corrao G, Rojas DP, Ciardo D, Fanetti G, Dicuonzo S, Mantovani M, Gerardi MA, Dell'Acqua V, Morra A, Fodor C, Galimberti VE, Veronesi P, Cattani F, Orecchia R, Jereczek-Fossa BA, Leonardi MC.

Med Oncol. 2019 Apr 29;36(6):51. doi: 10.1007/s12032-019-1273-1.

PMID:
31037520
5.

E-cadherin germline mutations in Māori population.

De Scalzi AM, Bonanni B, Galimberti V, Veronesi P, Pravettoni G, Corso G.

Future Oncol. 2019 Apr;15(12):1291-1294. doi: 10.2217/fon-2018-0834. Epub 2019 Apr 12. No abstract available.

6.

Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series.

Leonardi MC, Corrao G, Frassoni S, Vingiani A, Dicuonzo S, Lazzeroni M, Fodor C, Morra A, Gerardi MA, Rojas DP, Dell'Acqua V, Marvaso G, Bassi FD, Galimberti VE, Veronesi P, Miglietta E, Cattani F, Zurrida S, Bagnardi V, Viale G, Orecchia R, Jereczek-Fossa BA.

Radiother Oncol. 2019 Apr;133:68-76. doi: 10.1016/j.radonc.2018.12.030. Epub 2019 Jan 17.

PMID:
30935584
7.

Secondary breast angiosarcoma: A multicentre retrospective survey by the national Italian association of Breast Surgeons (ANISC).

Taffurelli M, Pellegrini A, Meattini I, Orzalesi L, Tinterri C, Roncella M, Terribile D, Caruso F, Tazzioli G, Pollini G, Friedman D, Mariotti C, Cianchetti E, Cabula C, Thomas R, Cedolini C, Rovera F, Grassi M, Lucani G, Cappella A, Bortul M, Stacul G, Scarabeo F, Procaccini E, Galimberti V.

Breast. 2019 Jun;45:56-60. doi: 10.1016/j.breast.2019.02.011. Epub 2019 Mar 7.

PMID:
30877870
8.

Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: A retrospective consecutive study.

Pece S, Disalvatore D, Tosoni D, Vecchi M, Confalonieri S, Bertalot G, Viale G, Colleoni M, Veronesi P, Galimberti V, Di Fiore PP.

EBioMedicine. 2019 Apr;42:352-362. doi: 10.1016/j.ebiom.2019.02.036. Epub 2019 Mar 5.

9.

Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.

Magnoni F, Massari G, Santomauro G, Bagnardi V, Pagan E, Peruzzotti G, Galimberti V, Veronesi P, Sacchini VS.

Br J Surg. 2019 Mar;106(4):375-383. doi: 10.1002/bjs.11079. Epub 2019 Feb 21.

10.

Clinical implication of E-cadherin deficiency in lobular breast cancer.

Corso G, Pravettoni G, Galimberti V, Veronesi P.

Breast Cancer Res Treat. 2019 Feb;173(3):751-752. doi: 10.1007/s10549-018-5051-0. Epub 2018 Nov 17. No abstract available.

PMID:
30448898
11.

Oncological Outcomes of Nipple-Sparing Mastectomy: A Single-Center Experience of 1989 Patients.

Galimberti V, Morigi C, Bagnardi V, Corso G, Vicini E, Fontana SKR, Naninato P, Ratini S, Magnoni F, Toesca A, Kouloura A, Rietjens M, De Lorenzi F, Vingiani A, Veronesi P.

Ann Surg Oncol. 2018 Dec;25(13):3849-3857. doi: 10.1245/s10434-018-6759-0. Epub 2018 Sep 17.

PMID:
30225833
12.

Nipple-sparing mastectomy with different approaches: surgical incisions, complications, and cosmetic results. Preliminary results of 100 consecutive patients at a single center.

Corso G, De Lorenzi F, Vicini E, Pagani G, Veronesi P, Sargenti M, Magnoni F, Naninato P, Maisonneuve P, Sangalli C, Rietjens M, Galimberti V.

J Plast Reconstr Aesthet Surg. 2018 Dec;71(12):1751-1760. doi: 10.1016/j.bjps.2018.07.022. Epub 2018 Aug 3.

PMID:
30197065
13.

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01.

Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5.

PMID:
30196031
14.

Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy.

Weber WP, Haug M, Kurzeder C, Bjelic-Radisic V, Koller R, Reitsamer R, Fitzal F, Biazus J, Brenelli F, Urban C, Paulinelli RR, Blohmer JU, Heil J, Hoffmann J, Matrai Z, Catanuto G, Galimberti V, Gentilini O, Barry M, Hadar T, Allweis TM, Olsha O, Cardoso MJ, Gouveia PF, Rubio IT, de Boniface J, Svensjö T, Bucher S, Dubsky P, Farhadi J, Fehr MK, Fulco I, Ganz-Blättler U, Günthert A, Harder Y, Hauser N, Kappos EA, Knauer M, Landin J, Mechera R, Meani F, Montagna G, Ritter M, Saccilotto R, Schwab FD, Steffens D, Tausch C, Zeindler J, Soysal SD, Lohsiriwat V, Kovacs T, Tansley A, Wyld L, Romics L, El-Tamer M, Pusic AL, Sacchini V, Gnant M.

Breast Cancer Res Treat. 2018 Dec;172(3):523-537. doi: 10.1007/s10549-018-4937-1. Epub 2018 Sep 4. Review.

15.

Could radiotherapy play a major role in misidentification of sentinel lymph node in breast cancer recurrence?

Lissidini G, Trifirò G, Veronesi P, Grana C, Zurrida S, Galimberti V, Corso G, Vellani C, Ivaldi GB.

Radiother Oncol. 2019 Feb;131:237-238. doi: 10.1016/j.radonc.2018.08.001. Epub 2018 Aug 30.

PMID:
30174108
16.

Dosimetric study to assess the feasibility of intraoperative radiotherapy with electrons (ELIOT) as partial breast irradiation for patients with cardiac implantable electronic device (CIED).

Luraschi R, Lazzari R, Galimberti V, Rondi E, Bazani A, Corso G, Colombo N, Ricotti R, Fodor C, Winnicki M, Leonardi MC, Jereczek-Fossa BA, Cattani F.

Breast Cancer Res Treat. 2018 Oct;171(3):693-699. doi: 10.1007/s10549-018-4878-8. Epub 2018 Jul 5.

PMID:
29978418
17.

Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.

Corso G, Figueiredo J, La Vecchia C, Veronesi P, Pravettoni G, Macis D, Karam R, Lo Gullo R, Provenzano E, Toesca A, Mazzocco K, Carneiro F, Seruca R, Melo S, Schmitt F, Roviello F, De Scalzi AM, Intra M, Feroce I, De Camilli E, Villardita MG, Trentin C, De Lorenzi F, Bonanni B, Galimberti V.

J Med Genet. 2018 Jul;55(7):431-441. doi: 10.1136/jmedgenet-2018-105337. Epub 2018 Jun 21.

PMID:
29929997
18.

Granular cell tumor of the breast: Molecular pathology and clinical management.

Corso G, Di Nubila B, Ciccia A, De Camilli E, Vicini E, Trentin C, Lissidini G, Cairns L, Veronesi P, Galimberti V.

Breast J. 2018 Sep;24(5):778-782. doi: 10.1111/tbj.13036. Epub 2018 Jun 13.

PMID:
29900629
19.

Ipsilateral Breast Tumor Reappearance and Contralateral Breast Cancer after Primary Breast Cancer Treatment: A Comprehensive Retrospective Study of 15,168 Patients.

Corso G, Maisonneuve P, Santomauro GI, De Scalzi AM, Toesca A, Bassi FD, Farante G, Caldarella P, Intra M, Galimberti V, Veronesi P.

Oncology. 2018;95(3):147-155. doi: 10.1159/000488764. Epub 2018 May 30.

PMID:
29847835
20.

Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysis.

De Lorenzi F, Di Bella J, Maisonneuve P, Rotmensz N, Corso G, Orecchia R, Colleoni M, Mazzarol G, Rietjens M, Loschi P, Marcelli S, Veronesi P, Galimberti V.

Eur J Surg Oncol. 2018 Jul;44(7):957-962. doi: 10.1016/j.ejso.2018.04.015. Epub 2018 Apr 24.

PMID:
29759643
21.

Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations.

Corso G, De Scalzi A, Feroce I, Veronesi P, Bonanni B, Galimberti V.

Per Med. 2018 May 1;15(3):153-155. doi: 10.2217/pme-2017-0083. Epub 2018 May 10. No abstract available.

PMID:
29745790
22.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B.

Ann Oncol. 2018 Oct 1;29(10):2153. doi: 10.1093/annonc/mdx806. No abstract available.

PMID:
29733336
23.

Sentinel lymph node biopsy management after neoadjuvant treatment for breast cancer care.

Corso G, De Scalzi AM, Vicini E, Morigi C, Veronesi P, Galimberti V.

Future Oncol. 2018 Jun;14(15):1423-1426. doi: 10.2217/fon-2018-0132. Epub 2018 May 1. No abstract available.

24.

Is periodontitis a risk indicator for cancer? A meta-analysis.

Corbella S, Veronesi P, Galimberti V, Weinstein R, Del Fabbro M, Francetti L.

PLoS One. 2018 Apr 17;13(4):e0195683. doi: 10.1371/journal.pone.0195683. eCollection 2018.

25.

Neoadjuvant systemic treatment for breast cancer in Italy: The Italian Society of Surgical Oncology (SICO) Breast Oncoteam survey.

Vicini E, Invento A, Cuoghi M, Bafile A, Battaglia C, Biglia N, Busani M, Bussone R, Cianchetti E, Caruso F, Cucchi MC, Dessena M, Di Filippo F, Fabi N, Folli S, Friedman D, Macellari G, Mainente P, Murgo R, Neri A, Pollini GP, Palli D, Ricci F, Scalco G, Taffurelli M, Trunfio M, Galimberti V; Italian Society of Surgical Oncology (SICO) Breast Oncoteam.

Eur J Surg Oncol. 2018 Aug;44(8):1157-1163. doi: 10.1016/j.ejso.2018.03.018. Epub 2018 Mar 31.

PMID:
29653781
26.

Prognosis and outcome in CDH1-mutant lobular breast cancer.

Corso G, Veronesi P, Sacchini V, Galimberti V.

Eur J Cancer Prev. 2018 May;27(3):237-238. doi: 10.1097/CEJ.0000000000000405. No abstract available.

PMID:
29595757
27.

The Italian Ministry of Health promotes more than 300 research projects to improve cancer prevention, treatment, and prognosis.

Corso G, Macis D, Veronesi P, Bonanni B, Galimberti V.

Eur J Cancer Prev. 2018 May;27(3):287-288. doi: 10.1097/CEJ.0000000000000443. No abstract available.

PMID:
29570106
28.

Multiple primary non-breast tumors in breast cancer survivors.

Corso G, Veronesi P, Santomauro GI, Maisonneuve P, Morigi C, Peruzzotti G, Intra M, Sacchini V, Galimberti V.

J Cancer Res Clin Oncol. 2018 May;144(5):979-986. doi: 10.1007/s00432-018-2621-9. Epub 2018 Mar 3.

PMID:
29502170
29.

Electron Beam Intraoperative Radiotherapy (ELIOT) in Pregnant Women with Breast Cancer: From in Vivo Dosimetry to Clinical Practice.

Leonardi M, Cecconi A, Luraschi R, Rondi E, Cattani F, Lazzari R, Morra A, Soto S, Zanagnolo V, Galimberti V, Gentilini O, Peccatori F, Jereczek-Fossa B, Orecchia R.

Breast Care (Basel). 2017 Dec;12(6):396-400. doi: 10.1159/000479862. Epub 2017 Dec 13.

30.

Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer.

Corso G, Bonanni B, Veronesi P, Galimberti V.

Arch Gynecol Obstet. 2018 Apr;297(4):1067-1068. doi: 10.1007/s00404-018-4705-9. Epub 2018 Feb 3. No abstract available.

PMID:
29397440
31.

Intra-operative radiotherapy management for breast cancer treatment in patients with pseudoxanthoma elasticum: A case report.

Salerno C, Vento AR, Giacchino M, Lissidini G, Galimberti V, Corso G.

Breast J. 2018 May;24(3):385-387. doi: 10.1111/tbj.12944. Epub 2017 Nov 5.

PMID:
29105951
32.

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

Dubsky P, Curigliano G, Burstein HJ, Winer EP, Gnant M, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B; Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B.

Ann Oncol. 2018 Jan 1;29(1):281-282. doi: 10.1093/annonc/mdx543. No abstract available.

33.

Prognostic impact of germline mutations in inherited cancer syndromes.

Corso G, Feroce I, Intra M, Veronesi P, Sacchini V, Bonanni B, Galimberti V.

Future Oncol. 2017 Oct;13(24):2125-2127. doi: 10.2217/fon-2017-0296. Epub 2017 Oct 6. No abstract available.

PMID:
28984488
34.

Feasibility of lymphoscintigraphy for sentinel node identification after neo-adjuvant therapy.

Corso G, Grana CM, Gilardi L, Baio SM, De Lorenzo D, Maisonneuve P, Rotmensz N, Ballardini B, Lissidini G, Ratini S, Bassi FD, Veronesi P, Galimberti V.

Ann Ital Chir. 2017;88:201-205.

PMID:
28874624
35.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Curigliano G, Burstein HJ, P Winer E, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B; St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017, André F, Baselga J, Bergh J, Bonnefoi H, Y Brucker S, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Hussein K, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B.

Ann Oncol. 2017 Aug 1;28(8):1700-1712. doi: 10.1093/annonc/mdx308.

36.

Improved prognosis of young patients with breast cancer undergoing breast-conserving surgery.

Botteri E, Veronesi P, Vila J, Rotmensz N, Galimberti V, Thomazini MV, Viale G, Orecchia R, Goldhirsch A, Gentilini O.

Br J Surg. 2017 Dec;104(13):1802-1810. doi: 10.1002/bjs.10658. Epub 2017 Aug 9.

PMID:
28791694
37.

Hereditary diffuse gastric cancer in two families: A case report.

Feroce I, Serrano D, Biffi R, Andreoni B, Galimberti V, Sonzogni A, Bottiglieri L, Botteri E, Trovato C, Marabelli M, Ranzani GN, Bonanni B.

Oncol Lett. 2017 Aug;14(2):1671-1674. doi: 10.3892/ol.2017.6354. Epub 2017 Jun 8.

38.

Axillary blue sentinel lymph node: an unusual tattoo?

Corso G, Mattar Fanianos D, Galimberti V, Intra M.

Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1940-1941. doi: 10.1007/s00259-017-3772-7. Epub 2017 Jul 15. No abstract available.

PMID:
28711995
39.

PIK3CA oncogenic mutations in neoadjuvant treatments for breast cancer.

Corso G, Veronesi P, Intra M, Sacchini V, Galimberti V.

Biomark Med. 2017 Jul;11(7):519-521. doi: 10.2217/bmm-2017-0048. Epub 2017 Jul 12. No abstract available.

PMID:
28700273
40.

Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique.

Toesca A, Peradze N, Galimberti V, Manconi A, Intra M, Gentilini O, Sances D, Negri D, Veronesi G, Rietjens M, Zurrida S, Luini A, Veronesi U, Veronesi P.

Ann Surg. 2017 Aug;266(2):e28-e30. doi: 10.1097/SLA.0000000000001397. No abstract available.

PMID:
28692558
41.

The Veronesi quadrantectomy: an historical overview.

Corso G, Veronesi P, Sacchini V, Galimberti V, Luini A.

Ecancermedicalscience. 2017 Jun 8;11:743. doi: 10.3332/ecancer.2017.743. eCollection 2017.

42.

Nipple-sparing and skin-sparing mastectomy: Review of aims, oncological safety and contraindications.

Galimberti V, Vicini E, Corso G, Morigi C, Fontana S, Sacchini V, Veronesi P.

Breast. 2017 Aug;34 Suppl 1:S82-S84. doi: 10.1016/j.breast.2017.06.034. Epub 2017 Jun 30. Review.

43.

Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells.

Rodvold JJ, Chiu KT, Hiramatsu N, Nussbacher JK, Galimberti V, Mahadevan NR, Willert K, Lin JH, Zanetti M.

Sci Signal. 2017 Jun 6;10(482). pii: eaah7177. doi: 10.1126/scisignal.aah7177.

44.

BRCA1/2 germline missense mutations: a systematic review.

Corso G, Feroce I, Intra M, Toesca A, Magnoni F, Sargenti M, Naninato P, Caldarella P, Pagani G, Vento A, Veronesi P, Bonanni B, Galimberti V.

Eur J Cancer Prev. 2018 May;27(3):279-286. doi: 10.1097/CEJ.0000000000000337.

PMID:
28277317
45.

Autophagy regulates UBC9 levels during viral-mediated tumorigenesis.

Mattoscio D, Casadio C, Miccolo C, Maffini F, Raimondi A, Tacchetti C, Gheit T, Tagliabue M, Galimberti VE, De Lorenzi F, Pawlita M, Chiesa F, Ansarin M, Tommasino M, Chiocca S.

PLoS Pathog. 2017 Mar 2;13(3):e1006262. doi: 10.1371/journal.ppat.1006262. eCollection 2017 Mar.

46.

Ipsilateral axillary recurrence after breast conservative surgery: The protective effect of whole breast radiotherapy.

Gentilini O, Botteri E, Leonardi MC, Rotmensz N, Vila J, Peradze N, Thomazini MV, Jereczek BA, Galimberti V, Luini A, Veronesi P, Orecchia R.

Radiother Oncol. 2017 Jan;122(1):37-44. doi: 10.1016/j.radonc.2016.12.021. Epub 2017 Jan 4.

PMID:
28063695
47.

From the maximum tolerable to the minimum effective treatment: The Umberto Veronesi's life commitment to breast cancer care.

Curigliano G, Cardoso F, Costa A, Galimberti V, Goldhirsch A, Pelicci PG, Veronesi P, Viale G, Orecchia R.

Breast. 2017 Feb;31:241-243. doi: 10.1016/j.breast.2016.11.013. Epub 2016 Nov 19. No abstract available.

PMID:
27876474
48.

Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study.

Toesca A, Peradze N, Manconi A, Galimberti V, Intra M, Colleoni M, Bonanni B, Curigliano G, Rietjens M, Viale G, Sacchini V, Veronesi P.

Breast. 2017 Feb;31:51-56. doi: 10.1016/j.breast.2016.10.009. Epub 2016 Nov 2.

49.

Fine structural detection of calcium ions by photoconversion.

Poletto V, Galimberti V, Guerra G, Rosti V, Moccia F, Biggiogera M.

Eur J Histochem. 2016 Aug 10;60(3):2695. doi: 10.4081/ejh.2016.2695.

50.

The stress-inducible transcription factor ATF4 accumulates at specific rRNA-processing nucleolar regions after proteasome inhibition.

Galimberti V, Kinor N, Shav-Tal Y, Biggiogera M, Brüning A.

Eur J Cell Biol. 2016 Oct;95(10):389-400. doi: 10.1016/j.ejcb.2016.08.002. Epub 2016 Aug 20.

PMID:
27567537

Supplemental Content

Loading ...
Support Center